MAUL, Julia-Tatjana et al. Tildrakizumab Treatment for Psoriasis in Real-world Practice: An Analysis from the Swiss Registry (SDNTT). Acta Dermato-Venereologica, [S. l.], v. 104, p. adv40946, 2024. DOI: 10.2340/actadv.v104.40946. Disponível em: https://medicaljournalssweden.se/actadv/article/view/40946. Acesso em: 12 feb. 2025.